Company

Delix Therapeutics

Biotechnology Research Boston, Massachusetts, United States 29 employees

Employees: 29
Contacts: 4
Emails: 4
Phones: 2

www.delixtherapeutics.com LinkedIn Crunchbase

Delix Therapeutics Overview

Headquarters: Boston, Massachusetts, United States
Website: www.delixtherapeutics.com
Industry: Biotechnology Research
Employees: 29
Founded: 2019
Funding: 825.0K
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

commitment he brings to #TeamDelix every day.

About Delix Therapeutics

Delix Therapeutics is applying modern tools of pharmaceutical development to some of nature's most ancient therapies, psychedelics. Through its discovery platform, Delix has identified a new class of non-hallucinogenic versions of psychedelic compounds with favorable safety and therapeutic profiles. Delix is rapidly advancing these psychoplastogen compounds through preclinical and clinical development, with the goal of one day alleviating mental suffering through its FDA-approved, take-home medicines.

Delix Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage
Phone contacts: 2; 50.0% coverage

Delix Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Tricia Mccall	Chief People Officer, Delix Therapeutics	Greater Boston, United States	Email Phone
Craig Asher	Managing Director at Omx Ventures	Washington, District of Columbia, United States	Email
Paul Conley		Palo Alto, California, United States	Email Phone
Milan Chytil, Phd	Biotech Builder - Drug Discovery Exec	Greater Boston, United States	Email